Search
- ICYMI: Breast cancer research breakthroughs discussed at #ESMO25 by @danafarber.bsky.social's Breast Oncology Center. Learn how these discoveries will impact clinical care going forward: 🎥 bit.ly/4j4fa4x
- 📰 #Cancer : l’IA révolutionne la #recherche mais pose question pour le traitement des patients. Le Pr Fabrice André rappelle que l'impact clinique de l'IA en oncologie reste à démontrer avant une adoption massive. ⬇ #ESMO #ESMO25
- 📰 Prévention du #cancer : Drugprev liste les médicaments efficaces. Découvrez l'expertise du Dr Alexandre Xu-Vuillard dans @lequotidiendumedecin.fr ⬇ #ESMO #ESMO25
- 📻 @franceinter.fr relaie l'analyse du Pr Barlesi, qui anticipe une montée en puissance des anticorps conjugués développés par l’industrie pharmaceutique chinoise, marquant un tournant stratégique pour le secteur. ⬇ #ESMO #ESMO25
- 📻 Le Pr Benjamin Besse insiste sur l'impact majeur avancées thérapeutiques, et plus particulièrement les anticorps conjugués. A découvrir sur Radio Classique ⬇ #ESMO #ESMO25
- 🔹 Dr. Maria Alice Franzoi - Digital tools to support patients after treatments. #ESMO #ESMO25 @myesmo.bsky.social
- 🔹 Dr. Antonio Di Meglio - Needs of cancer survivors in a era of new therapies. #ESMO #ESMO25 @myesmo.bsky.social
- #ESMO25 | Studies of the French national coordination on unknown primary cancers (CUP) led by Institut Curie show the importance of a collaborative and multidisciplinary approach to improve targeted treatments in these rare cancers. Learn more: ➡️ institut-curie.org/esmo2025 #OncSky #CUP
- #ESMO25 | New insights from the IMMUNOBIL phase II trial presented by Dr Matthieu Delaye (Institut Curie): a combination of 2 immunotherapies in advanced biliary tract cancer after platinum-based chemo shows promising survival for a subgroup of patients. ➡️ institut-curie.org/esmo2025
- 🔹 Congratulations to Chayma Bousrih and Federica Giugliano, winners of the #ESMO Merit Awards 2025. #ESMO25 @myesmo.bsky.social
- 🔹 Poster session for experts at @gustaveroussy.fr. 👩⚕️ Dr. Benjamin Verret 👨⚕️ Dr. Chayma Bousrih #ESMO #ESMO25
- 🔹 Poster session for experts at @gustaveroussy.fr. 👩⚕️ Dr. Petya Zyumbileva 👨⚕️ Dr. Francesco Facchinetti 👩⚕️ Dr. Marie Morfouace #ESMO #ESMO25
- #ESMO25 | Physicians and researchers from @institutcurie.bsky.social delighted to share their latest advances, innovations, and expertise to accelerate discoveries in #oncology for the benefit of patients 🤝 Learn more: 📍https://institut-curie.org/esmo2025 📍Booth Institut Curie / Hall 2.2b - #2036
- 🔹 Dr. Maria Fernanda Mosele, Discussant at the Mini oral metastatic breast cancer session - how do our patients feel with new treatment regimens for mBC. #ESMO #ESMO25 @myesmo.bsky.social
- 🔹 Dr. Killian Carnet-Le Prévost presented a study which evaluated the correlation between esmo-mcbs score and early-access decisions in France, in the mini-oral Policy session. #ESMO #ESMO25 @myesmo.bsky.social
- 🔹 Dr. Ines Vaz Luis presenting patient reported-outcomes and quality of life data from the phase III PATINA trial at the Mini Oral Metastatic Breast Cancer Session. #ESMO #ESMO25 @myesmo.bsky.social
- 🔹 Dr. Stefan Michiels advocating for tumor agnostic approaches at @myesmo.bsky.social. #ESMO #ESMO25
- 🔹 Pr. Yohann Loriot explains the progress of the study presented at the presidential election, of which he is co-author, in patients with bladder #cancer. #ESMO #ESMO25 @myesmo.bsky.social
- 🔹 Poster session for experts at @gustaveroussy.fr. 👨⚕️ Congratulations to Dr. Pablo Berlanga for winning the award for best poster on therapeutic developments with the ESMART arm O poster (futibatinib, first in child) presented at #ESMO25. #ESMO @myesmo.bsky.social
- 🔹 Pr. Fabrice Barlesi reviews the results of two studies presented at the #ESMO conference on lung #cancer. #ESMO25 @myesmo.bsky.social
- 🔹 @drchoueiri.bsky.social and Pr. @fandremd.bsky.social chair Sunday's presidential session at @myesmo.bsky.social, in front of a packed audience of 9,000 people. #ESMO #ESMO25
- 🔹 Dr. Arnaud Bayle discussed the patient voice at the Policy mini oral session at @myesmo.bsky.social. #ESMO25 #ESMO
- 🔹 Pr. Laurence Albiges: What are the major changes in GU Oncology practice after #ESMO25? #ESMO @myesmo.bsky.social
- 🔹 @gustaveroussy.fr at #ESMO25 🔹 When the tumour microenvironment hinders the effectiveness of Car-T cell therapies. Press release: ow.ly/1PLi50Xezwe #ESMO @myesmo.bsky.social
- 🔹 Educational Session on Progress in thoracic oncology: Dr. Jordi Remon discussing on resectable NSCLC with actionable genomic alteration at @myesmo.bsky.social. #ESMO #ESMO25
- #ESMO25 | New insights from the SOHO-01 study presented by Prof. NIcolas Girard @institutcurie.bsky.social: Molecular factors and ctDNA dynamics may help predict outcomes in patients with HER2-mutant #NSCLC treated with sevabertinib, paving the way for more personalized care. #medonc #lungcancer
- 🔹 Poster session for experts at @GustaveRoussy. 👨⚕️ Dr. Thomas Pudlarz 👨⚕️ Dr. Antony Tarabay #ESMO #ESMO25
- 🔹 Poster session for experts at @GustaveRoussy. 👨⚕️ Dr. Tarek Ben Ahmed 👩⚕️ Dr. Kaissa Ouali 👨⚕️ Pr. Michel Ducreux #ESMO #ESMO25
- 🔹 Poster session for experts at @gustaveroussy.fr. 👨⚕️ Dr. Tarek Ben Ahmed 👩⚕️ Dr. Maria Alice Franzoi 👨⚕️ Dr. Pedro Cacilhas #ESMO #ESMO25
- 🔹 Pr. Christophe Massard reviews the progress made with new drugs at @myesmo.bsky.social. #ESMO #ESMO25
